RS & RS Scientific raises €518K Seed round
15 October 2024· Stevenage, United Kingdom· health, drug_discovery, biotech, materials, b2b, deep_hardware
The funding was raised to support the development of 'InhaleGene', an inhalable precision gene therapy for lung cancer, specifically focusing on the in-vitro program and early delivery workstreams.
Investors
LeadDiscovery Park Ventures
Also participating
SFC CapitalStevenage Bioscience Catalyst
About RS & RS Scientific
Stage
Seed
Headquarters
Stevenage, United Kingdom
Founded
2022
Team Size
6–20
Sectors
healthdrug_discoverybiotechmaterialsb2bdeep_hardware